iifl-logo

Nippon India Pharma Fund Direct IDCW

Nippon India Pharma Fund Direct IDCW

Fund Name

Nippon India Mutual Fund

Scheme Name

Nippon India Pharma Fund Direct IDCW

AMC

Nippon India Mutual Fund

Type

:  Open

Category

Equity - Pharma

Launch Date

01-Jan-2013

Fund Manager

Sailesh Raj Bhan

Net Assets (Rs. cr)

8259.6

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Nippon India Pharma Fund Direct IDCW - Nav Details

Nav Date

:  06-Jun-2025

NAV [Rs.]

:  167.006

Buy/Resale Price [Rs.]

0

Sell/Repurchase Price [Rs.]

0

Entry Load %

Exit Load %

Nippon India Pharma Fund Direct IDCW- NAV Chart

Nippon India Pharma Fund Direct IDCW- Performance(%)

Returns above 1 yr. are annualized

1W
1M
3M
6M
1Y
3Y
5Y
Since INC
Scheme Returns
0.52
2.37
9.79
-1.37
16.58
25.53
22.69
18.88
Category Avg
0.64
1.74
8.92
-3.8
19.89
24.84
22.23
17.69
Category Best
1.32
5.25
15.13
-0.14
30.95
29.5
26.01
36.02
Category Worst
-0.06
-0.33
4.57
-8.85
11.81
20.12
16.87
-4.96

Nippon India Pharma Fund Direct IDCW- Latest Dividends

Record DateDividend %Bonus
21-Feb-20241000

Nippon India Pharma Fund Direct IDCW- Investment Details

Min. Investment(Rs.)

5000

Increm.Investment(Rs.)

1000

In & Out

In

InName Of The CompanyNo Of Shares
Akums Drugs3,13,305

Out

InName Of The CompanyNo Of Shares
--

Fund Holdings

Asset Type
Instrument Name
Industry
Net Assets(%)
No of Shares
Mkt Value(Cr.)
Equity & Equity related Investments
EquitySun Pharma.Inds.Pharmaceuticals & Biotechnology13.8862563491,146.35
EquityDivi's Lab.Pharmaceuticals & Biotechnology9.571298808790.58
EquityLupinPharmaceuticals & Biotechnology6.302483991520.54
EquityCiplaPharmaceuticals & Biotechnology6.013200000496.03
EquityApollo HospitalsHealthcare Services5.48648795452.66
EquityDr Reddy's LabsPharmaceuticals & Biotechnology5.253662170433.56
EquityGlaxosmi. PharmaPharmaceuticals & Biotechnology3.631011921299.99
EquityMedplus HealthRetailing3.543627277292.41
EquityVijaya Diagnost.Healthcare Services3.432831564283.29
EquityAbbott IndiaPharmaceuticals & Biotechnology3.2388883266.51
EquityAjanta PharmaPharmaceuticals & Biotechnology3.14959323259.60
EquityNarayana HrudayaHealthcare Services3.041426170251.07
EquityGland PharmaPharmaceuticals & Biotechnology2.591529352214.10
EquityAurobindo PharmaPharmaceuticals & Biotechnology2.531702630209.27
EquityDr Lal PathlabsHealthcare Services2.38709112196.36
EquityZydus Lifesci.Pharmaceuticals & Biotechnology2.152000632177.70
EquityTorrent Pharma.Pharmaceuticals & Biotechnology2.02503364167.21
EquityAlkem LabPharmaceuticals & Biotechnology2.00323678165.59
EquityJ B Chemicals &Pharmaceuticals & Biotechnology1.95999649161.18
EquityMankind PharmaPharmaceuticals & Biotechnology1.94649036160.00
EquityThyrocare Tech.Healthcare Services1.881765838155.05
EquitySanofi IndiaPharmaceuticals & Biotechnology1.66230272136.85
EquityPfizerPharmaceuticals & Biotechnology1.65318249136.61
EquityIpca Labs.Pharmaceuticals & Biotechnology1.33785412110.05
EquitySanofi ConsumerPharmaceuticals & Biotechnology1.28213659105.54
EquitySai LifePharmaceuticals & Biotechnology1.21143042399.67
EquitySuraksha Diagno.Healthcare Services1.15316961894.83
EquityFortis Health.Healthcare Services0.92110388975.67
EquityBioconPharmaceuticals & Biotechnology0.89228422273.50
EquitySyngene Intl.Healthcare Services0.86112479571.31
EquityAstrazeneca PharPharmaceuticals & Biotechnology0.676407855.62
EquityIndoco RemediesPharmaceuticals & Biotechnology0.52183492442.67
EquityOrchid PharmaPharmaceuticals & Biotechnology0.4849272739.46
EquityEmcure PharmaPharmaceuticals & Biotechnology0.3730184130.84
EquityKrishna Institu.Healthcare Services0.3746178530.33
EquityConcord BiotechPharmaceuticals & Biotechnology0.2111173816.96
EquityAkums DrugsPharmaceuticals & Biotechnology0.2031330516.36
Cash & Cash Equivalent
Reverse RepoTREPS-/-0.36029.77
Cash & Cash EquivalentC C I-/-0.0000.18
Net CA & OthersNet CA & Others-/--0.070-5.85

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

MY WEALTH AT RETIREMENT

Calculate the worth of your wealth at retirement

Key information

Fund House:
Nippon India Mutual Fund
Incorporation Date:
24-Feb-1995
Total Assets Managed (Cr.):
5,61,387.15
Trustee/s:
Mr. A N Shanbhag - Associ, Nippon Life India Trustee
Chairman:
NA
CEO / MD:
Mr. Sundeep Sikka
CIO:
NA
President:
NA
Director/s:
Mr. Akira Shibata, Mr. Sushil C. Tripathi, Mr. Kazuhide Toda, Mr. Takayuki Murai
Compliance Officer/s:
Mr. Muneesh Sud
Investor Service Officer/s:
Mr. Milind Nesarikar
Fund Manager/s:
Sailesh Raj Bhan
Auditors:
Haribhakti & Co LLP Chart

OTHER INFORMATION

Registered Office:
4th Floor, Tower A, Peninsula Busines -s Park, Ganapatrao Kadam Marg Lower Parel (W), Mumbai - 400013.
Contact Nos:
022-68087000/1860260111
Fax:
022-68087097
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.